
CORTI NICOLÒ
Pubblicazioni
Corti, N., Ricci, E., Faltoni, M., Mezzadri, M., Fois, M., De Vito, A., et al. (2025). Impact of cefiderocol therapy on patient survival across different multi drug-resistant Gram-negative bacilli infections: insights from the SUSANA cohort. Intervento presentato a: ESCMID Global 2025. Congress of the European Society of Clinical Microbiology and Infectious Diseases, Vienna. Dettaglio
Corti, N., Ricci, E., Faltoni, M., Mezzadri, L., Fois, M., De Vito, A., et al. (2025). Impact of cefiderocol therapy on patient survival across different multidrugresistant Gram-negative bacilli infections.. Intervento presentato a: XII Workshop Nazionale CISAI, Milano. Dettaglio
Mezzadri, L., Ricci, E., Merli, M., Corti, N., Faltoni, M., Bandera, A., et al. (2025). Ceftazidime-avibactam plus aztreonam versus cefiderocol in the treatment of infections caused by Metallo-β lactamase-Producing Microorganisms: real-word data from the Italian cohort SUSANA. Intervento presentato a: ESCMID Global 2025. Congress of the European Society of Clinical Microbiology and Infectious Diseases, Vienna. Dettaglio
Faltoni, M., Ricci, E., Mezzadri, L., Corti, N., Bisi, L., Fois, M., et al. (2025). Comparison of meropenem-vaborbactam vs ceftazidime-avibactam in the treatment of KPC producing Klebsiella pneumoniae infections. Intervento presentato a: ESCMID Global 2025. Congress of the European Society of Clinical Microbiology and Infectious Diseases, Vienna. Dettaglio
Cavazza, G., Motto, C., Regna-Gladin, C., Travi, G., Di Gennaro, E., Peracchi, F., et al. (2024). Cerebral Infectious Opportunistic Lesions in a Patient with Acute Myeloid Leukaemia: The Challenge of Diagnosis and Clinical Management. ANTIBIOTICS, 13(5) [10.3390/antibiotics13050387]. Dettaglio